Cargando…

Current evidence of antifungal prophylaxis and therapy in pediatric patients

Invasive fungal infections (IFI) are an important complication in pediatric haematological and oncological patients who undergo intensive chemotherapy for leukemia, solid tumour at advanced stage or relapsed, and hematopoietic stem cell transplantation. The incidence of IFI is lower than bacterial i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giacchino, Mareva, Milano, Giuseppe Maria, Carraro, Francesca, Bezzio, Stefania, Pegoraro, Anna, Aversa, Franco, Cesaro, Simone
Formato:	Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103132/ https://www.ncbi.nlm.nih.gov/pubmed/21647279 http://dx.doi.org/10.4081/pr.2011.e6

Ejemplares similares

Preventing transmission of infectious agents in the pediatric in-patients hematology-oncology setting: what is the role for non-pharmacological prophylaxis?
por: Caselli, Désirée, et al.
Publicado: (2011)

Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy
por: Licciardello, Maria, et al.
Publicado: (2011)

Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
por: Cesaro, Simone, et al.
Publicado: (2014)

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients
por: Cesaro, Simone, et al.
Publicado: (2007)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic stem cell transplantation
por: Cesaro, Simone, et al.
Publicado: (2011)

Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)

Analysis of early infectious complications in pediatric patients undergoing bone marrow transplantation
por: Busca, A., et al.
Publicado: (1999)

Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
por: Döring, M., et al.
Publicado: (2015)

Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016)

The Impact of Chemotherapy after Pediatric Malignancy on Humoral Immunity to Vaccine-Preventable Diseases
por: Garonzi, Chiara, et al.
Publicado: (2020)

Epidemiology, risk factors and therapy of candidemia in pediatric hematological patients
por: Cugno, Chiara, et al.
Publicado: (2012)

Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation
por: Lehrnbecher, Thomas, et al.
Publicado: (2023)

Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia
por: Tu, Songji, et al.
Publicado: (2023)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
por: Stemler, Jannik, et al.
Publicado: (2022)

Clinical practice update of antifungal prophylaxis in immunocompromised children
por: Ramos, José Tomás, et al.
Publicado: (2019)

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
por: Villaescusa, Teresa, et al.
Publicado: (2020)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?
por: Perreault, Sarah, et al.
Publicado: (2023)

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Döring, Michaela, et al.
Publicado: (2012)

Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
por: Lehrnbecher, Thomas, et al.
Publicado: (2020)

Correction Notice: Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
Publicado: (2022)

Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
por: Cataldo, Maria Adriana, et al.
Publicado: (2011)

Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants
por: Takahashi, Daijiro, et al.
Publicado: (2009)

Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
por: Awotiwon, Ajibola A, et al.
Publicado: (2018)

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
por: Hawes, Armani M., et al.
Publicado: (2022)

Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation
por: Döring, M., et al.
Publicado: (2013)

Combination Antifungal Therapy: A Review of Current Data
por: Campitelli, Marco, et al.
Publicado: (2017)

Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
por: Amico, K. Rivet, et al.
Publicado: (2014)

Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice
por: Ferrarese, Alberto, et al.
Publicado: (2021)

Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children
por: Ferreras-Antolín, Laura, et al.
Publicado: (2021)

Current Trends in Antifungal Prophylaxis for High-Risk Neonates in Neonatal Intensive Care Units in India: A Nationwide Survey
por: Arun, Sumitha, et al.
Publicado: (2023)

Aspiring Antifungals: Review of Current Antifungal Pipeline Developments
por: Gintjee, Thomas J., et al.
Publicado: (2020)

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
por: Döring, Michaela, et al.
Publicado: (2012)

Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence
por: Misra, Sanghamitra M.
Publicado: (2014)

Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study
por: Riedel, Amy, et al.
Publicado: (2007)

Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
por: Gedik, Habip, et al.
Publicado: (2014)

Benefits of risk‐adapted and mould‐specific antifungal prophylaxis in childhood leukaemia
por: Meryk, Andreas, et al.
Publicado: (2020)

Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections
por: Brunet, Kévin, et al.
Publicado: (2022)

Adenovirus Infection in Pediatric Hematopoietic Cell Transplantation: A Challenge Still Open for Survival
por: Cesaro, Simone, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lgrqe6j9u3qkf32gcugvmrdfig